Plaque sealing - A concept waiting for support

International Journal of Cardiovascular Interventions

Volumn 7, Issue 2, 2005, Pages 72-74

  Colombo, Antonio ^a   Iakovou, Ioannis ^a  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CORONARY STENT; DRUG ELUTING STENT; HUMAN; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENOSIS; TECHNIQUE;

CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; HUMANS; PACLITAXEL; STENTS;

EID: 23944460028     PISSN: 14628848     EISSN: None     Source Type: Journal    
DOI: 10.1080/14628840510039531     Document Type: Note

References (19)

1. Meier B. Plaque sealing by coronary angioplasty. Heart. 2004;90:1395-8.
2. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157-66.
3. Ellis S, Alderman E, Cain K, Fisher L, Sanders W, Bourassa M. Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS Registry Study. J Am Coll Cardiol. 1988;11:908-16.
4. Hamon M, Bauters C, McFadden EP, Lablanche JM, Bertrand ME. Six-month quantitative angiographic follow-up of <50% diameter stenoses dilated during multilesion percutaneous transluminal coronary angioplasty. Am J Cardiol. 1993;71:1226-9.
5. Meier B. Ramamurthy S. Plaque sealing by coronary angioplasty. Cathet Cardiovasc Diagn. 1995;36:295-7.
6. Ischinger T, Gruentzig AR, Hollman J, et al. Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty? Circulation. 1983;68:148-54.
7. Mercado N, Maier W, Boersma E, et al. Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J. 2003;24:541-51.
8. Bech GJ, De Bruyne B, Pijls NH, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103:2928-34.
9. Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary instent restenosis: a randomized controlled trial. JAMA. 2005;293:165-71.
10. Iakovou I, Ge L, Michev I, et al. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions. J Am Coll Cardiol. 2004;44:967-71.
11. Colombo A, Iakovou I. Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation. Eur Heart J. 2004;25:895-7.
12. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31.
13. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-80.
14. Hoye A, Lemos PA, Arampatzis CA, et al. Effectiveness of sirolimus-Eluting stent implantation for coronary narro-wings <50% in diameter. Am J Cardiol. 2004;94:112-4.
15. O'Neill WW, Leon MB. Drug-eluting stents: costs versus clinical benefit. Circulation. 2003;107:3008-11.
16. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701-5.
17. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, Predictors, and Outcome of Thrombosis after Successful Implantation of Drug-Eluting Stents. JAMA. 2005;293:2126-30.
18. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation. 2004;109:1930-2.
19. Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005;45:947-53.